Gene · 730249
Papers2,030
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,030
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impact of dental loupes and operating microscopes on restorative performance of preclinical and clinical dental students: a pilot study. | BMC Med Educ | 2026 | 41749196 | PubTator, text mining | PubMed |
| IRG1-itaconate axis in immunometabolism: mechanistic roles and therapeutic potential in inflammatory diseases. | Front Immunol | 2026 | 41743716 | PubTator, text mining | PubMed |
| ACOD1 expression in patients with sepsis: an exploratory study of associations with disease severity and immune signatures. | BMC Infect Dis | 2026 | 41742056 | PubTator, text mining | PubMed |
| Exploring cooperation among social pathogens: a computational perspective. | FEMS Microbiol Rev | 2026 | 41733245 | PubTator, text mining | PubMed |
| Assessment of dynamic cerebral blood flow changes during cognitive tasks in patients with post-COVID-19 syndrome. | Brain Commun | 2026 | 41728261 | PubTator, text mining | PubMed |
| Role of trained immunity in DCs and macrophages in the induction of Th2 responses and allergy treatment. What do we know? | Front Immunol | 2026 | 41727488 | PubTator, text mining | PubMed |
| Metabolic control of neuroinflammation: focus on itaconate and its derivatives in CNS disorders. | Front Immunol | 2026 | 41727487 | PubTator, text mining | PubMed |
| Monogenic forms of inflammatory bowel disease: Genetic mechanisms, models, and clinical implications. | Mol Med | 2026 | 41714924 | PubTator, text mining | PubMed |
| Docosahexaenoic acid supplementation inhibits monocyte exhaustion memory formation during sepsis. | Inflamm Res | 2026 | 41703318 | PubTator, text mining | PubMed |
| Cytotoxic CD4 T Cells: Dual Agents in HIV-1 Pathogenesis and Persistence. | Curr HIV/AIDS Rep | 2026 | 41697467 | PubTator, text mining | PubMed |
| Targeting Acod1/itaconate in cancer therapy: Mechanisms and opportunities. | Pharmacol Res | 2026 | 41692038 | PubTator, text mining | PubMed |
| F-Box Protein-Mediated Proteolytic Regulation of Phenylpropanoid Metabolism in Response to Biotic and Abiotic Stresses. | Plant Cell Environ | 2026 | 41691449 | PubTator, text mining | PubMed |
| Programming Next-Generation Synthetic Biosensors by Genetic Circuit Design. | Adv Sci (Weinh) | 2026 | 41655251 | PubTator, text mining | PubMed |
| ZFTA-RELA ependymomas make itaconate to epigenetically drive fusion expression. | Nature | 2026 | 41639460 | PubTator, text mining | PubMed |
| The KEAP1/NRF2 axis controls LPS-induced oxidative stress, inflammasome activation and caspase-1 activity in human endothelial cells. | PLoS One | 2026 | 41637413 | PubTator, text mining | PubMed |
| Timing of Glucocorticoid Treatment Dictates Glucocorticoid Receptor Actions Modulating the NLRP3-Inflammasome Activation in Macrophages. | FASEB J | 2026 | 41623187 | PubTator, text mining | PubMed |
| Dihydroartemisinin Promotes N1 Polarization of Tumor-Associated Neutrophils and Enhances Their Anti-Tumor Activity via Hub Gene Modulation. | Pharmaceuticals (Basel) | 2026 | 41599687 | PubTator, text mining | PubMed |
| Metabolomics and Transcriptomics Analyses Explore the Genes Related to the Biosynthesis of Antioxidant Active Ingredient Isoquercetin. | Foods | 2026 | 41596816 | PubTator, text mining | PubMed |
| Epigenetic and post-translational regulatory networks of ferroptosis in the tumor immune microenvironment. | Exp Hematol Oncol | 2026 | 41588554 | PubTator, text mining | PubMed |
| Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications. | Signal Transduct Target Ther | 2026 | 41582215 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/730249/papers?page=4